TD Securities (USA)’s Edwards Lifesciences EW Stock Holding History

TD Securities (USA)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$4K	Hold	144	–	–	0.04%	232
2015 Q4	$4K	Sell	144 -222	-61%	-$5.76K	0.04%	233
2015 Q3	$9K	Sell	366 -260,994	-100%	-$6.3M	0.08%	249
2015 Q2	$6.2M	Buy	261,360 +28,920	+12%	+$653K	0.08%	282
2015 Q1	$5.52M	Sell	232,440 -11,292	-5%	-$253K	0.08%	280
2014 Q4	$5.17M	Buy	243,732 +21,198	+10%	+$426K	0.07%	310
2014 Q3	$3.79M	Buy	222,534 +1,260	+0.6%	+$19.9K	0.06%	349
2014 Q2	$3.17M	Buy	221,274 +10,122	+5%	+$137K	0.05%	403
2014 Q1	$2.61M	Sell	211,152 -20,448	-9%	-$236K	0.05%	426
2013 Q4	$2.54M	Buy	231,600 +954	+0.4%	+$10.8K	0.04%	438
2013 Q3	$2.68M	Sell	230,646 -456	-0.2%	-$5.33K	0.05%	413
2013 Q2	$2.59M	Buy	+231,102	New	+$2.74M	0.05%	398

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

TD Securities (USA)'s EW Position: Q1 2016 in Review

TD Securities (USA) held its Edwards Lifesciences (EW) position steady in Q1 2016 at 144 shares worth $4K. The position accounts for 0.04% of the portfolio, ranked #232.

TD Securities (USA) first reported a position in EW in Q2 2013 and has held it in 12 quarters since. The position peaked at $6.2M in Q2 2015. 659 funds tracked by Wall St. Rank hold EW as of Q1 2016.

TD Securities (USA) held 144 shares of Edwards Lifesciences worth $4K as of Q1 2016.
TD Securities (USA) left its Edwards Lifesciences share count unchanged in Q1 2016.
Edwards Lifesciences made up 0.04% of TD Securities (USA)'s portfolio in Q1 2016, its #232 holding.
TD Securities (USA) first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 12 quarters since.
TD Securities (USA)'s Edwards Lifesciences position peaked at $6.2M in Q2 2015.
659 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.